Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: Case report and review of the literature

Clinical Microbiology and Infection

Volumn 16, Issue 5, 2010, Pages 508-512

  Salmon, A ^a   Debourgogne, A ^b   Vasbien, M ^b   Clement L ^a   Collomb, J ^b   Plenat F ^b   Bordigoni, P ^a   Machouart, M ^b  

^a HÔPITAL D ENFANTS   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

Antifungals; Diagnosis; Opportunist; Scopulariopsis; Transplantation

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; CASPOFUNGIN; CEFTAZIDIME; CYCLOSPORIN; MYCOPHENOLIC ACID; POSACONAZOLE; STEROID; TEICOPLANIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYALOHYPHOMYCOSIS; LOADING DRUG DOSE; LUNG ASPERGILLOSIS; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SCOPULARIOPSIS BREVICAULIS; SKIN BIOPSY; SKIN INFECTION; SYSTEMIC MYCOSIS;

ASPERGILLUS; SCOPULARIOPSIS; SCOPULARIOPSIS BREVICAULIS;

EID: 77952930057     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02878.x     Document Type: Article

References (48)

1. De Hoog GS, Guarro J, Gene J, Figueres MJ. Atlas of clinical fungi2000, 2nd edn, Utrecht, the Netherlands, Centraalbureau voor schimmelcultures
2. Tosti A, Piraccini BM, Stinchi C, Lorenzi S. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals. Br J Dermatol 1996, 135:799-802.
3. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000, 42:217-224.
4. Cox NH, Irving B. Cutaneous 'ringworm' lesions of Scopulariopsis brevicaulis. Br J Dermatol 1993, 129:726-728.
5. Ginarte M, Pereiro M, Fernández-Redondo V, Toribio J. Plantar infection by Scopulariopsis brevicaulis. Dermatology 1996, 193:149-151.
6. Gariano RF, Kalina RE. Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis. Retina 1997, 17:256-258.
7. Oh BJ, Chae MJ, Cho D. Infection with Scopulariopsis brevicaulis after cosmetic surgery of the face. Korean J Lab Med 2006, 26:32-35.
8. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob Agents Chemother 2003, 47:2339-2341.
9. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005, 41:521-526.
10. Reiss E, Tanaka K, Bruker G. Molecular diagnosis and epidemiology of fungal infections. Med Mycol 1998, 36:249-257.
11. Wakayama M, Shibuya K, Ando T. Deep-seated mycosis as a complication in bone marrow transplantation patients. Mycoses 2002, 45:146-151.
12. Schinabeck MK, Ghannoum MA. Human hyalohyphomycoses: a review of human infections due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp. J Chemother 2003, 15(suppl 2):5-15.
13. Richardson M, Lass-Flörl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008, 14:5-24.
14. Sellier P, Monsuez JJ, Lacroix C. Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. Clin Infect Dis 2000, 30:820-823.
15. Karam A, Hery G, Eveillard JR. Subcutaneous mycosis due to Scopulariopsis brevicaulis in an aplasic patient. Ann Dermatol Venereol 2003, 130:783-786.
16. Endo S, Hironaka M, Murayama F, Yamaguchi T, Sohara Y, Saito K. Scopulariopsis fungus ball. Ann Thorac Surg 2002, 74:926-927.
17. Dhar J, Carey PB. Scopulariopsis brevicaulis skin lesions in an AIDS patient. AIDS 1993, 7:1283-1284.
18. Martel J, Faisant M, Lebeau B, Pinel C, Feray C, Feuilhade M. Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient. Ann Dermatol Venereol 2001, 128:130-133.
19. Ragge NK, Dean Hart JC, Easty DL, Tyers AG. A case of fungal keratitis caused by Scopulariopsis brevicaulis treatment with antifungal agents and penetrating keratoplasty. Br J Ophthalmol 1990, 74:561-562.
20. Malecha MA. Fungal keratitis caused by Scopulariopsis brevicaulis treated successfully with natamycin. Cornea 2004, 23:201-203.
21. Lotery AJ, Kerr JR, Page BA. Fungal keratitis caused by Scopulariopsis brevicaulis: successful treatment with topical amphotericin B and chloramphenicol without the need for surgical debridement. Br J Ophthalmol 1994, 78:730.
22. Aydin S, Ertugrul B, Gultekin B, Uyar G, Kir E. Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy. BMC Infect Dis 2007, 7:87.
23. Ustun C, Huls G, Stewart M, Marr KA. Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor. Mycopathologia 2006, 162:299-302.
24. Mohammedi I, Piens MA, Audigier-Valette C. Fatal Microascus trigonosporus (anamorph Scopulariopsis) pneumonia in a bone marrow transplant recipient. Eur J Clin Microbiol Infect Dis 2004, 23:215-217.
25. Isidro AM, Amorosa V, Stopyra GA, Rutenberg HL, Pentz WH, Bridges CR. Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature. J Thorac Cardiovasc Surg 2006, 131:1181-1183.
26. Chen-Scarabelli C, Scarabelli TM. Fungal endocarditis due to Scopulariopsis. Ann Intern Med 2003, 139:77.
27. Migrino RQ, Hall GS, Longworth DL. Deep tissue infections caused by Scopulariopsis brevicaulis: report of a case of prosthetic valve endocarditis and review. Clin Infect Dis 1995, 21:672-674.
28. Gentry LO, Nasser MM, Kielhofner M. Scopulariopsis endocarditis associated with Duran ring valvuloplasty. Tex Heart Inst J 1995, 22:81-85.
29. Baddley JW, Moser SA, Sutton DA, Pappas PG. Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient. J Clin Microbiol 2000, 38:395-397.
30. Nwabuisi C, Salami AK, Abdullahi NA, Agbede OO. Scopulariopsis associated meningitis in adult Nigerian AIDS patient-a case report. West Afr J Med 2003, 22:364-365.
31. Wuyts WA, Molzahn H, Maertens J. Fatal Scopulariopsis infection in a lung transplant recipient: a case report. J Heart Lung Transplant 2005, 24:2301-2304.
32. Neglia JP, Hurd DD, Ferriere P, Snover DC. Invasive Scopulariopsis in the immunocompromised host. Am J Med 1987, 83:1163-1166.
33. Wheat LJ, Bartlett M, Ciccarelli M, Smith JW. Opportunistic Scopulariopsis pneumonia in an immunocompromised host. South Med J 1984, 77:1608-1609.
34. Creus L, Umbert P, Torres-Rodriguez JM, Lopez-Gil F. Ulcerous granulomatous cheilitis with lymphatic invasion caused by Scopulariopsis brevicaulis infection. J Am Acad Dermatol 1994, 31:881-883.
35. Krisher KK, Holdridge NB, Mustafa MM, Rinaldi MG, McGough DA. Disseminated Microascus cirrosus infection in pediatric bone marrow transplant recipient. J Clin Microbiol 1995, 33:735-737.
36. Wagner D, Sander A, Bertz H, Finke J, Kern WV. Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis. Infection 2005, 33:397-400.
37. Steinbach WJ, Schell WA, Miller JL, Perfect JR, Martin PL. Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. J Infect 2004, 48:112-116.
38. Einsele H, Loeffler J. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients. Clin Microbiol Infect 2008, 14:37-45.
39. Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE. Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother 2004, 48:1989-1992.
40. Ng KP, Soo-Hoo TS, Na SL, Gan GG, Sangkar JV, Teh AK. Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia. Med J Malaysia 2003, 58:608-612.
41. Aguilar C, Pujol I, Guarro J. In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother 1999, 43:1520-1522.
42. Schlemmer F, Lagrange-Xélot M, Lacroix C, de La Tour R, Socié G, Molina JM. Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation. Bone Marrow Transplant 2008, 42:551-552.
43. Ananda-Rajah MR, Grigg A, Slavin MA. Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis. Mycopathologia 2008, 166:83-86.
44. Kishel JJ, Sivik J. Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up. J Oncol Pharm Pract 2008, 14:189-193.
45. Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother 2006, 50:2248-2250.
46. Johnson EM, Szekely A, Warnock DW. In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens. Antimicrob Agents Chemother 1999, 43:1260-1263.
47. Carrillo-Muñoz AJ, Giusiano G, Guarro J. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents 2007, 30:157-161.
48. Ryder NS. Activity of terbinafine against serious fungal pathogens. Mycoses 1999, 42:115-119.